Apixaban for AF in ESRD: Fewer Strokes, Major Bleeds vs Warfarin Apixaban for AF in ESRD: Fewer Strokes, Major Bleeds vs Warfarin

' I think this is the best data we have so far ' supporting the use of apixaban in the especially high-risk population with atrial fibrillation, the lead researcher concludes. A randomized trial is forthcoming.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news